Cover Image
市場調查報告書

生物性骨材市場分析:產品,用途,終端用戶,各地區預測

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 447156
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物性骨材市場分析:產品,用途,終端用戶,各地區預測 Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment Forecasts, 2014 - 2025
出版日期: 2017年01月16日 內容資訊: 英文 100 Pages
簡介

本報告提供生物性骨材的全球市場調查,提供您產品,用途,終端用戶,各地區的市場趨勢及市場佔有率分析·預測,推動、阻礙市場要素,及SWOT分析,市場魅力度·波特的五力分析,競爭情形,並彙整主要企業的簡介等資訊。

第1章 調查手法與調查範圍

第2章 摘要整理

第3章 生物性骨材市場:趨勢與範圍

  • 市場區隔與市場範圍
  • 市場推動因素
  • 市場阻礙因素
  • 滲透度·成長預測的製圖
  • SWOT分析
  • 波特的五力分析

第4章 生物性骨材市場:各產品

  • 生物性骨材市場:產品分析
  • 脫礦骨基質(DBM)
    • 脫礦骨基質(DBM)市場預測
  • 同種骨移植片
    • 同種骨移植片市場預測
  • 骨形成蛋白(BMP)
    • 骨形成蛋白(BMP)市場預測
  • 關節內補充藥
    • 關節內補充藥市場預測
  • 合成人工骨替代材料
    • 合成人工骨替代材料市場預測
  • 幹細胞療法
    • 幹細胞療法市場預測

5章 生物性骨材市場:各用途

  • 生物性骨材市場:用途分析
    • 脊椎融合手術
    • 脊椎融合手術市場預測
  • 重組手術
    • 重組手術市場預測
  • 外傷手術
    • 外傷手術市場預測

第6章 生物性骨材市場:各終端用戶

  • 生物性骨材市場:終端用戶分析
  • 醫院
  • 接骨院

第7章 生物性骨材市場:各地區

  • 生物性骨材市場:各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭情形

  • 策略組成架構
  • 市場進入類別
  • 企業簡介
目錄
Product Code: GVR-1-68038-360-7

The global orthobiologics market is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics market is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.

These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics market during the forecast period.

Further Key Findings From the Study Suggest:

  • In 2015, viscosupplementation accounted for the largest share in the product segment owing to being a cost efficient therapeutic alternative for symptomatic management of osteoarthritis
  • Spinal fusion held the largest share in the application segment in 2015, owing to presence of third party insurers and reimbursement structure for fusion enhancement products thus triggering growth
  • In 2015, North America accounted for the dominant share owing to consistent efforts of industry players in promoting awareness pertinent to the orthobiological products resulting in significant rise in adoption rate
  • Asia Pacific is anticipated to exhibit an exponential CAGR as a consequence of significant surge in healthcare spending and awareness levels with respect to the availability of orthobiologics
  • The prominent players are consistently indulging into extensive strategies to gain competitive position including regional expansion and mergers & acquisitions to capture a greater market share
  • For instance, in November 2015, Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This acquisition was carried out to expand orthobiologics product portfolio and grafting solutions in order to expand their market share

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region Wise Market: Base Estimates
    • 1.1.2 Global Market: CAGR Calculation
  • 1.2 Region based segment share calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Orthobiologics Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
  • 3.2 Market Driver Analysis
  • 3.3 Market Restraint Analysis
  • 3.4 Penetration & growth prospect mapping
  • 3.5 Orthobiologics - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's

Chapter 4 Orthobiologics Market: Product Estimates & Trend Analysis

  • 4.1 Orthobiologics market: Product movement analysis
  • 4.2 Demineralized Bone Matrix (DBM)
    • 4.2.1 DBM market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.3 Allograft
    • 4.3.1 Allograft market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.4 Bone Morphogenetic Protein (BMP)
    • 4.4.1 BMP market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.5 Viscosupplementation
    • 4.5.1 Viscosupplementation market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.6 Synthetic Bone Substitutes
    • 4.6.1 Synthetic bone substitutes market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.7 Stem Cell Therapy
    • 4.7.1 Stem cell therapy market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 5 Orthobiologics Market: Application Estimates & Trend Analysis

  • 5.1 Orthobiologics market: Application movement analysis
  • 5.2 Spinal Fusion
    • 5.2.1 Spinal fusion market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 5.3 Trauma Repair
    • 5.3.1 Trauma repair market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 5.4 Reconstructive Surgery
    • 5.4.1 Reconstructive surgery market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 6 Orthobiologics Market: End-use Estimates & Trend Analysis

  • 6.1 Orthobiologics market: End-use movement analysis
  • 6.2 Hospitals
    • 6.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 6.3 Orthopedic Clinics
    • 6.3.1 Orthopedic clinics market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 7 Orthobiologics: Regional Estimates & Trend Analysis, by Product, Application & End-use

  • 7.1 Orthobiologics market shares by region, 2015 & 2024
  • 7.2 North America
    • 7.2.1 North America orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
    • 7.2.3 Canada
      • 7.2.3.1 Canada orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
  • 7.3 Europe
    • 7.3.1 Europe orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.3.2 Germany
      • 7.3.2.1 Germany orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.3.3 UK
      • 7.3.3.1 UK orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.2 Japan
      • 7.4.2.1 Japan orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.3 China
      • 7.4.3.1 China orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.4 India
      • 7.4.4.1 India orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 7.5 Latin America
    • 7.5.1 Latin America orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 7.6 MEA
    • 7.6.1 MEA orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Strategy framework
  • 8.2 Market participation categorization
  • 8.3 Company Profiles
    • 8.3.1 Bone Biologics, Corp.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Medtronic
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Bioventus LLC
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Pioneer Surgical Technology
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 Smith & Nephew plc
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Stryker Corporation
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 DePuy Synthes, Inc.
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Financial Performance
      • 8.3.7.3 Product Benchmarking
      • 8.3.7.4 Strategic Initiatives
    • 8.3.8 Genzyme
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Financial Performance
      • 8.3.8.3 Product Benchmarking
      • 8.3.8.4 Strategic Initiatives
    • 8.3.9 Osiris Therapeutics, Inc.
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Globus Medical
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Financial Performance
      • 8.3.10.3 Product Benchmarking
      • 8.3.10.4 Strategic Initiatives
    • 8.3.11 Wright Medical Technology
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives
    • 8.3.12 Orthofix, Inc.
      • 8.3.12.1 Company Overview
      • 8.3.12.2 Financial Performance
      • 8.3.12.3 Product Benchmarking
      • 8.3.12.4 Strategic Initiatives
    • 8.3.13 NuVasive, Inc.
      • 8.3.13.1 Company Overview
      • 8.3.13.2 Financial Performance
      • 8.3.13.3 Product Benchmarking
      • 8.3.13.4 Strategic Initiatives
    • 8.3.14 Zimmer Biomet
      • 8.3.14.1 Company Overview
      • 8.3.14.2 Financial Performance
      • 8.3.14.3 Product Benchmarking
      • 8.3.14.4 Strategic Initiatives
    • 8.3.15 Anthrex
      • 8.3.15.1 Company Overview
      • 8.3.15.2 Financial Performance
      • 8.3.15.3 Product Benchmarking
      • 8.3.15.4 Strategic Initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 3 North America orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 4 North America orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 5 U.S. orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 8 Canada orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 11 Europe orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 12 Europe orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 14 Germany orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 15 Germany orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 16 Germany orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 17 UK orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 18 UK orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 19 UK orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 20 Asia Pacific orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 21 Asia Pacific orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 22 Asia Pacific orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 23 Japan orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 24 Japan orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 25 Japan orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 26 China orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 27 China orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 28 China orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 29 India orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 30 India orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 31 India orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 32 Latin America orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 33 Latin America orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 34 Latin America orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 35 Brazil orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 36 Brazil orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 37 Brazil orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 38 Mexico orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 39 Mexico orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 40 Mexico orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 41 MEA orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 42 MEA orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 43 MEA orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 44 South Africa orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 45 South Africa orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 46 South Africa orthobiologics market, by end-use, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market summary (USD Billion)
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Orthobiologics market product outlook key takeaways
  • FIG. 10 Orthobiologics market: Product movement analysis
  • FIG. 11 Global DBM market, 2014 - 2025 (USD Billion)
  • FIG. 12 Global allograft market, 2014 - 2025 (USD Billion)
  • FIG. 13 Global machined bones market, 2014 - 2025 (USD Billion)
  • FIG. 14 Global BMP market, 2014 - 2025 (USD Billion)
  • FIG. 15 Global viscosupplementation market, 2014 - 2025 (USD Billion)
  • FIG. 16 Global synthetic bone substitutes market, 2014 - 2025 (USD Billion)
  • FIG. 17 Global stem cell therapy market, 2014 - 2025 (USD Billion)
  • FIG. 18 Global others market, 2014 - 2025 (USD Billion)
  • FIG. 19 Orthobiologics market application outlook: Key takeaways
  • FIG. 20 Orthobiologics market: Application movement analysis
  • FIG. 21 Global spinal fusion market, 2014 - 2025 (USD Billion)
  • FIG. 22 Global trauma repair market, 2014 - 2025 (USD Billion)
  • FIG. 23 Global reconstructive surgery market, 2014 - 2025 (USD Billion)
  • FIG. 24 Orthobiologics market end-use outlook: Key takeaways
  • FIG. 25 Orthobiologics market: End-use movement analysis
  • FIG. 26 Global hospitals market, 2014 - 2025 (USD Billion)
  • FIG. 27 Global orthopedic clinics market, 2014 - 2025 (USD Billion)
  • FIG. 28 Regional market place: Key takeaways
  • FIG. 29 Regional outlook, 2015 & 2024
  • FIG. 30 North America orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 31 U.S. orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 32 Canada orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 33 Europe orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 34 Germany orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 35 UK orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 36 Asia Pacific orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 37 Japan orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 38 China orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 39 India orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 40 Latin America orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 41 Brazil orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 42 Mexico orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 43 MEA orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 44 South Africa orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 45 Strategy framework
  • FIG. 46 Participant categorization
Back to Top